# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001776985-26-000055
Filing Date
2026-08-04
Accepted
2026-08-04 07:01:36
Documents
5
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | form6-kq22026quarterlyrepo.htm | 6-K | 14873
2 | EX-99.1 | bntxq22026ex991quarterlyre.htm | EX-99.1 | 2813882
3 |  | a260407_coverxq2a.jpg | GRAPHIC | 2756318
4 |  | fsridynmyoja6mda5mdg4zmfky.gif | GRAPHIC | 118
5 |  | fsridynmyoja6mzkwzmyyzjzkz.gif | GRAPHIC | 122
| Complete submission text file | 0001776985-26-000055.txt |  | 6626879

Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 261235398
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)